PARIJS–(BUSINESS WIRE)– Opgericht in 2018, is Incepto een uniek platform op de markt dat artsen en ziekenhuizen toegang biedt tot een portfolio van oplossingen op basis van kunstmatige intelligentie, ontworpen om de kwaliteit van diagnoses te verbeteren en tijd te besparen voor medische teams, zonder van apparatuur te hoeven wisselen. Om haar groei op Europese schaal te ondersteunen, haalt Incepto vandaag € 27 miljoen op. De financieringsronde wordt geleid door het Venture – Digital Health-team van LBO France, met deelname van Wille Finance en de historische investeerders AXA Venture Partners, het Patient Autonome-fonds van Bpifrance en Karista. Deze financiering markeert een nieuwe fase voor Incepto, dat zijn aanbod lanceert in vier nieuwe landen in Europa (Duitsland, Spanje, Italië en Portugal).

Als onderdeel van de ontwikkeling van Incepto worden vier nieuwe dochterondernemingen opgericht in Duitsland, Spanje, Italië en Portugal met als doel haar positie als Europese leider in de sector te verankeren en tegen 2024 één miljoen Europese patiënten per maand te behandelen.

Incepto, the French Digital Health Specialist, is Raising €27 million to Support Its European Development

PARIS–(BUSINESS WIRE)– Founded in 2018, Incepto is a unique platform on the market that offers doctors and hospitals access to a portfolio of solutions based on artificial intelligence, designed to improve the quality of diagnoses, and save time for medical teams, without having to change equipment. In order to support its growth at a European scale, Incepto is raising €27 million today. The financing round is led by LBO France’s Venture – Digital Health team, with the participation of Wille Finance and the historical investors AXA Venture Partners, the Patient Autonome fund of Bpifrance and Karista. This financing marks a new stage for Incepto, which is launching its offer in four new countries in Europe (Germany, Spain, Italy and Portugal).

As part of Incepto’s development, four new subsidiaries are created in Germany, Spain, Italy and Portugal with the aim of anchoring its position as European leader in the sector and treat one million European patients per month by 2024.

From a French start-up to a European scale-up

Incepto is also announcing the signing of five new partnerships (IB Lab, Milvue, PAIRE, SmartSoft and Thirona) to expand its portfolio of medical imaging applications for emergency care, oncology, orthopaedics, rheumatology and pneumology.

By extending its geographical coverage and developing its portfolio of applications, Incepto is responding to major public health issues: reducing waiting times for examinations, mitigating the lack of specialists for certain serious diseases and supporting doctors’ work in the face of the increasing amount of data to be analysed.

In light with the explosion of the AI market in Europe, Incepto has three strategic objectives:

▪ Selecting and make available the most powerful AI solutions in medical imaging for each specialty, guaranteeing high quality standards;

▪ Creating, with doctors new applications that meet real needs but that do not exist yet: ARVA and KEROS are thus the first products co-developed by Incepto for the diagnostic assistance of aortic aneurysms in CT scanners and for MRI of the knee;

▪ Supporting the transformation of organisations and working methods by rethinking patient care with medical teams to exploit the full potential of artificial intelligence technologies.

About Incepto

Created in 2018, Incepto is the first European platform for artificial intelligence solutions applied to medical imaging. With a hundred clinics equipped with their AI solutions and already more than 100,000 patients monitored every month, Incepto’s mission is twofold: to help doctors identify the most efficient solutions and put them at their service, while co-creating new applications with them, adapted to their specific needs. Incepto’s ambition is to assist doctors on a daily basis in improving the accuracy of diagnoses, the treatment process and the quality of patient care.

https://incepto-medical.com/fr

View source version on businesswire.com: https://www.businesswire.com/news/home/20220919005036/en/

Contacts

Press Contact
Aude Vayre : 00 33 6 14 64 15 65 / aude.vayre@grayling.com
Anne Levasseur : 00 33 6 68 52 14 09 / anne.levasseur@citigatedewerogerson.com